
Understanding Attitudes and Roles of Oncology Advanced Practitioners in the Setting of Cancer Clinical Trials: A Pilot Study
Author(s) -
Christa BraunInglis,
Yurii B. Shvetsov,
A. Springer,
Valerie Ferguson,
T. L. Workman,
Dee Ann Omatsu,
Francisco Conde,
Erin O’Carroll Bantum,
Jessica Rhee
Publication year - 2021
Publication title -
journal of the advanced practitioner in oncology
Language(s) - English
Resource type - Journals
eISSN - 2150-0886
pISSN - 2150-0878
DOI - 10.6004/jadpro.2021.12.5.2
Subject(s) - medicine , clinical trial , cronbach's alpha , family medicine , oncology nursing , health care , descriptive statistics , oncology , data collection , population , nursing , clinical psychology , nurse education , statistics , mathematics , environmental health , economics , economic growth , psychometrics
Oncology advanced practitioners (APs), including nurse practitioners, physician assistants, clinical nurse specialists, and pharmacists, are skilled health-care providers who contribute significantly to quality cancer care. However, little is known about how APs function within the clinical trials arena. With low rates of clinical trial enrollment among the adult oncology patient population, APs could play an important role in improving clinical trial enrollment.